-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LpfE1kCKc63Lz1OPtszs/nUQGBnzI427ylrB4XCtN9AqZsPJMxe6scVM38OBeQNn VCOyeyqjgXtJodGHwPKqng== 0000893220-09-000120.txt : 20090127 0000893220-09-000120.hdr.sgml : 20090127 20090127171122 ACCESSION NUMBER: 0000893220-09-000120 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090127 DATE AS OF CHANGE: 20090127 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BMP Sunstone CORP CENTRAL INDEX KEY: 0001281696 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 200434726 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81506 FILM NUMBER: 09548860 BUSINESS ADDRESS: STREET 1: 600 W. GERMANTOWN PIKE STREET 2: SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: 610-940-1675 MAIL ADDRESS: STREET 1: 600 W. GERMANTOWN PIKE STREET 2: SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 FORMER COMPANY: FORMER CONFORMED NAME: BEIJING MED PHARM CORP DATE OF NAME CHANGE: 20040225 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Abacus Investments Ltd. CENTRAL INDEX KEY: 0001332335 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: C/O BEIJING MED-PHARM CORPORATION STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: 610-940-1675 MAIL ADDRESS: STREET 1: C/O BEIJING MED-PHARM CORPORATION STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 SC 13D/A 1 w72448sc13dza.htm SC 13D/A sc13dza
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 4)
BMP Sunstone Corporation
 
(Name of Issuer)
Common Stock, par value $0.001 per share
 
(Title of Class of Securities)
077255107
 
(CUSIP Number)
David Gao
Chief Executive Officer
BMP Sunstone Corporation
600 W. Germantown Pike, Suite 400
Plymouth Meeting, Pennsylvania 19462
(610) 940-1675
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
January 27, 2009
 
(Date Of Event Which Requires Filing Of This Statement)
If the reporting person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f), or 13d-1(g), check the following box o.
 
 

 


 

                     
CUSIP No.
 
077255107  
13D Page  
  of   
5 Pages 

 

           
1   NAME OF REPORTING PERSONS

Abacus Investments Limited

S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)   o 
  (b)   o 
     
3   SEC USE ONLY
   
   
     
4   SOURCE OF FUNDS
   
  NA
     
5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)
   
  o
     
6   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Abacus Investments Limited is organized under the laws of Bermuda.
       
  7   SOLE VOTING POWER
     
NUMBER OF   7,907,484 Shares of Common Stock
       
SHARES 8   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   None
       
EACH 9   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   7,907,484 Shares of Common Stock
       
WITH 10   SHARED DISPOSITIVE POWER
     
    None
     
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  7,907,484 Shares of Common Stock
     
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
   
  o
     
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
   
  19.65%*
     
14   TYPE OF REPORTING PERSON
   
  CO
* Based on 40,246,410 outstanding shares of Common Stock as of November 7, 2008 (as reported in the Form 10-Q filed by BMP Sunstone Corporation with the Securities and Exchange Commission on November 10, 2008), calculated pursuant to Rule 13d-3 promulgated under the Securities Exchange Act of 1934

(Page 2 of 5 Pages)


 

Item 1. Security and Issuer
     This Amendment No. 4 (“Amendment No. 4”) relates to the Schedule 13D filed by Abacus Investments Limited (“Abacus”) with the Securities and Exchange Commission (the “Commission”) on November 22, 2006, as amended by Amendment No. 1, filed on December 22, 2006, Amendment No. 2, filed on November 20, 2007 and Amendment No. 3, filed on December 11, 2007 (as so amended, the “Schedule 13D”), with respect to the common stock, par value $0.001 per share (“Common Stock”), of BMP Sunstone Corporation, a Delaware corporation (the “Company”).
Item 4. Purposes of Transactions
     Item 4 is amended and restated as follows:
     Abacus has held all the shares of Common Stock beneficially owned by it for the purpose of investment. Abacus evaluates its investment on a continuing basis. On January 25, 2009, Abacus’ board of directors approved (i) a plan of complete liquidation of Abacus, (ii) the appointment of a liquidator to oversee the plan of complete liquidation and (iii) submission of such matters for a vote of the Abacus shareholders. On January 27, 2009, the Abacus shareholders approved each of these matters by majority written consent, and Abacus is proceeding with its plan of complete liquidation, which includes, among other things, an in kind pro rata distribution of the shares of Common Stock currently held by Abacus to its shareholders. Following the completion of the distribution, Abacus will no longer beneficially own any Common Stock. Abacus expects the distribution of shares of Common Stock to be completed in February 2009 and the liquidation to be completed in March 2009.
     The preceding information is being disclosed pursuant to Item 4(a) of Schedule 13D. Other than the potential liquidation and distribution described above, Abacus has no plan or proposals with respect to the Issuer that relate to or could result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D. Abacus, however, may at any time and from time to time, review or reconsider its position with respect to any of such matters.
Item 5. Interest in Securities of the Issuer
     Item 5(a) is amended and restated as follows:
     As of the date hereof, Abacus is the beneficial owner of 7,907,484 shares of Common Stock which constitutes approximately 19.65% of the Company’s 40,246,410 issued and outstanding shares of Common Stock, based on information contained in a Form 10-Q filed by the Company with the SEC on November 10, 2008.
     John F. Turben, Chairman and Chief Executive Officer of Abacus, is the owner of 43,478 shares of common stock. With the exception of Mr. Turben’s ownership, no executive officer or director owns any shares of Common Stock except for his or her indirect ownership of the Common Stock owned by Abacus.
[The remainder of this page is intentionally left blank.]

(Page 3 of 5 Pages)


 

SIGNATURE
          After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated: January 27, 2009  
         
  ABACUS INVESTMENTS LIMITED
 
 
  By:   /s/ Nicolas Hoskins   
    Name:   Nicolas Hoskins   
    Title:   Liquidator   

(Page 4 of 5 Pages)


 

         
SCHEDULE A
Abacus Investments Ltd.
                 
Name
  Position   Principal Occupation   Business Address   Citizenship
 
               
John F. Turben
  Director/Chairman &   Managing Partner of   Kirtland Capital Partners   U.S.A.
 
  CEO   Kirtland Capital   3201 Enterprise Parkway    
 
      Partners   Suite 200 Beachwood Ohio    
 
          44122 USA    
 
               
Sir John Craven
  Director   Chairman of   113 St. George’s Square   U.K & Canada
 
      Patagonia Gold plc   London SW1V 3QP    
 
          England    
 
               
Robert Mulderig
  Director/ Deputy   Chairman of   14 Par-la-Ville Road   U.K.
 
  Chairman   Woodmont Management   Hamilton, Bermuda HM 05    
 
      Ltd.        
 
               
Deanna Didyk
  Director   Managing Director   14 Par-la-Ville Road   Canada
 
      of Woodmont   Hamilton, Bermuda HM 05    
 
      Management Ltd.        
 
               
Helen Ann Chisholm
  Assistant Secretary   Executive   Suite 810, CIBC Bldg.   Canada
 
      Administrator of   1809 Barrington Street    
 
      Maritime Corporate   Halifax, Nova Scotia    
 
      Services Ltd.   Canada B3J 3K8    
 
               
Laurie Rayner
  Secretary   Senior   14 Par-la-Ville Road   U.K.
 
      Administrator of   Hamilton, Bermuda HM 05    
 
      Woodmont Management        
 
      Ltd.        
 
               
Lady Ning Craven
  Director   Director; Abacus   113 St. George’s Square   Canada
 
      Investments Limited   London SW1V 3QP    
 
          England    
 
               
Philip A. Embiricos
  Director   Director   Embiricos Shipbrokers Ltd.   Greece
 
          Commonwealth House    
 
          1-19 New Oxford Street    
 
          London WC1A 1NU    
 
          England    
 
               

(Page 5 of 5 Pages)

-----END PRIVACY-ENHANCED MESSAGE-----